FBIO trade ideas
FBIO LONG.I am thinking FBIO is a very positive stock to buy around 2.58-2.89. My FINAL target price of FBIO is around 7.31-10. IF I were you, I will buy around 2.66 and sell around 3.95 and start buying around 3.3-3.1.
$FBIO Fortress Biotech Inc Target PTs 5.25 --> 10 --> 12.70 --> NASDAQ:FBIO Fortress Biotech Inc
Target PTs 5.25 --> 10 --> 12.70 --> 17 and higher
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; MB-107 and MB-207 for the treatment of X-linked severe combined immunodeficiency; Cosibelimab for metastatic cancers; CK-101 for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and CEVA101 for the treatment of severe traumatic brain injury in adults and children. The company's early stage product candidates include MB-102 for blastic plasmacytoid dendritic cell neoplasm; MB-101 for glioblastoma; MB-104 for multiple myeloma and light chain amyloidosis; MB-106 for B-cell non-hodgkin lymphoma; MB-103 for GBM & metastatic breast cancer to brain; MB-108; MB-105 for prostate and pancreatic cancers; and BAER-101. Its preclinical product candidates comprise AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and ONCOlogues, and oligonucleotide platform. It has collaboration arrangements with universities, research institutes, and pharmaceutical companies. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.
Fortress Biotech, Inc. On the above bi-Weekly chart price action has corrected over 90%. A number of reasons now exist to be bullish , including:
1) A strong buy signal prints (not shown).
2) Regular bullish divergence. Multiple oscillators now print positive divergence.
3) 2-week hammer candle on support
4) No stock splits.
Is it possible price action falls further? Sure.
Is it probable? No.
Ww
Type: trade
Risk: <=6% of portfolio
Timeframe: Don’t know.
Return: Don’t know
Stop loss: <= 46 cents
FBIO - Bullish channel trade2021-11-19
Markets are mixed, possibly turning bearish (near all time highs)
FBIO has underperformed the market
FBIO is presently in a bullish channel
Bottom of channel has been tested 3x
Expected to continue trading within bullish channel upwards.
This is a technical trade. Hoping to touch my target for a sell. If this turns bullish and runs, will hold. No upcoming events to be concerned about.
Avg price: 3.09
profit taker = 3.54
loss = 2.94
I entered the trade hoping that this stock will stay inside the channel and not fall below.
FBIO a good 'speculative' swing trade This has been so good to me. I keep buying each time it goes into this particular drawn out 2/1 RR ratio. And I keep making a bit of money, then exit on declining volume.
The stock itself can be argued to be a really good long term hold. Going to watch for another swing for an easy few hundred bucks.
FBIO Repeating old swing trade Ran, came back down, nothing changed otherwise. Easy RR ratio setup for 2/1
See my old idea, do some research, this is trading well below analyst values.
FBIOThe swing trader in me is looking at the gap fill
The long term investor looks at the potential in 2 years.
The average analyst price is at 10.00, so I am watching this closely.
FBIO set an ATH and is bullish FBIO is an unbelievably attractive long term opportunity, that is trading well below the average analysts ratings.
"a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products." Yahoo stocks
It has strong buy ratings across the board. I doubled my position in it today. Looking to sell a 1/3rd in the $9 mark, a 1/3rd in the 10-10.50 and keep a 1/3rd for very long.
I do see it going up quickly in the short term. Specially if market conditions are favorable. We could see this start to gain attention and hit one of my targets sooner than expected. But all in all. This is not the one I would sell at a loss. I would hold this even 3-4 years out and stick to my targets.
-------------------------------------------------------
From a technical perspective
Clear bounce at 3.34 ish and is extremly attractive at thos prices.
Uptrend started March 30th. The MACD looks good, and today (friday) its out performing the market so far. Fridays are usually not great, so if it hold strong I am hoping it will do well next week and beyond.
FBIO BounceI am looking for an entry point near the 20 day ema...between 4.07-4.22. Resistance and 4.59 and a first target of 5.46
Fortress Biotech, Inc. 25% upside Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.
FBIO Announces Up to $5 Million Series A Cumulative Redeemable PFBIO,FBIOP: Fortress Biotech, Inc.
2020-03-23 09:20:10
Fortress Biotech Announces Up to $5 Million Series A Cumulative Redeemable Perpetual Preferred Stock Repurchase Program
Fortress Biotech, Inc. breakout potential Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company. The company was founded on June 28, 2006 in and is headquartered in New York, NY.
$FBIO FORTRESS BIOTECH INC, set you alerts for major moves.FBIO will almost move in carbon copy fashion to Mustang BIO so keep it on your watch-lists with buy orders in place for what could be a very frantic but rewarding move. Treat with caution and be agile for entry and exit.
Announces CAEL-101 Strategic Partnership with Alexion PharmaceutFortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee
Alexion has option to acquire Caelum Biosciences based on Phase 2 data
finance.yahoo.com
FBIO GOING TO TEST THE LOWER TRENDLINE?FBIO has rejected the upper trendline of this triangle and it's pointing down. I'm expecting one more wave down with a potential test on lower trendline.
